Literature DB >> 24374733

Disruption of THY-1 signaling in alveolar lipofibroblasts in experimentally induced congenital diaphragmatic hernia.

Florian Friedmacher1, Alejandro Daniel Hofmann, Hiromizu Takahashi, Toshiaki Takahashi, Jan-Hendrik Gosemann, Prem Puri.   

Abstract

PURPOSE: Pulmonary hypoplasia (PH), characterized by alveolar immaturity, remains the main cause of neonatal mortality and long-term morbidity in infants with congenital diaphragmatic hernia (CDH). Lipid-containing interstitial fibroblasts (LIFs) are critically important for normal alveolar development. Thymocyte antigen 1 (Thy-1) is a highly expressed cell-surface protein in this specific subset of lung fibroblasts, which plays a key role in fetal alveolarization by coordinating the differentiation and lipid homeostasis of alveolar LIFs. Thy-1 increases the lipid content of LIFs by upregulation of adipocyte differentiation-related protein (ADRP), a lipogenic molecular marker characterizing pulmonary LIFs. Thy-1 (-/-) mice further show impaired alveolar development with reduced proliferation of pulmonary LIFs, resulting in a PH-similar phenotype. We hypothesized that pulmonary Thy-1 signaling is disrupted in experimentally induced CDH, which may has an adverse effect on the lipid content of alveolar LIFs.
METHODS: Timed-pregnant Sprague-Dawley rats were treated with either 100 mg nitrofen or vehicle on embryonic day 9.5 (E9.5). Fetuses were killed on E21.5, and lungs were divided into controls (n = 14) and CDH-associated PH (n = 14). Pulmonary gene expression levels of Thy-1 and ADRP were assessed by quantitative real-time PCR. ADRP immunohistochemistry and oil-red-O staining were used to localize alveolar LIF expression and lipid droplets. Immunofluorescence double staining for Thy-1 and oil-red-O was performed to evaluate Thy-1 expression and lipid content in alveolar LIFs.
RESULTS: Radial alveolar count was significantly reduced in CDH-associated PH with significant downregulation of pulmonary Thy-1 and ADRP mRNA expression compared to controls. ADRP immunoreactivity and lipid droplets were markedly diminished in alveolar interstitial cells, which coincided with decreased alveolar LIF expression in CDH-associated PH compared to controls. Confocal laser scanning microscopy confirmed markedly decreased Thy-1 expression and lipid content in alveolar LIFs of CDH-associated PH compared to controls.
CONCLUSION: Our study provides strong evidence that disruption of pulmonary Thy-1 signaling results in reduced lipid droplets in alveolar LIFs and may thus contribute to PH in the nitrofen-induced CDH model. Treatment modalities aimed at increasing lipid content in alveolar LIFs may therefore have a therapeutic potential in attenuating CDH-associated PH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24374733     DOI: 10.1007/s00383-013-3444-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  30 in total

1.  Evidence for the presence of lipofibroblasts in human lung.

Authors:  Virender K Rehan; Sharon Sugano; Ying Wang; Jamie Santos; Sonia Romero; Chiranjib Dasgupta; Michael P Keane; Mildred T Stahlman; John S Torday
Journal:  Exp Lung Res       Date:  2006-09       Impact factor: 2.459

2.  Neutral lipid trafficking regulates alveolar type II cell surfactant phospholipid and surfactant protein expression.

Authors:  John Torday; Virender Rehan
Journal:  Exp Lung Res       Date:  2011-07-01       Impact factor: 2.459

3.  Follow-up of the survivors of congenital diaphragmatic hernia.

Authors:  Gustavo Rocha; Inês Azevedo; Jorge Correia Pinto; Hercília Guimarães
Journal:  Early Hum Dev       Date:  2011-09-23       Impact factor: 2.079

4.  Thy-1 signals through PPARγ to promote lipofibroblast differentiation in the developing lung.

Authors:  Brian M Varisco; Namasivayam Ambalavanan; Jeffrey A Whitsett; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-20       Impact factor: 6.914

5.  Role of adipose differentiation-related protein in lung surfactant production: a reassessment.

Authors:  Amy L Magra; Pamela S Mertz; John S Torday; Constantine Londos
Journal:  J Lipid Res       Date:  2006-08-25       Impact factor: 5.922

Review 6.  Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells.

Authors:  C Londos; D L Brasaemle; C J Schultz; J P Segrest; A R Kimmel
Journal:  Semin Cell Dev Biol       Date:  1999-02       Impact factor: 7.727

7.  Congenital diaphragmatic hernia with(out) ECMO: impaired development at 8 years.

Authors:  Marlous J Madderom; Leontien Toussaint; Monique H M van der Cammen-van Zijp; Saskia J Gischler; René M H Wijnen; Dick Tibboel; Hanneke Ijsselstijn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-12-12       Impact factor: 5.747

Review 8.  Congenital diaphragmatic hernia.

Authors:  Richard Keijzer; Prem Puri
Journal:  Semin Pediatr Surg       Date:  2010-08       Impact factor: 2.754

9.  The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro.

Authors:  J S Torday; E Torres; V K Rehan
Journal:  Pediatr Pathol Mol Med       Date:  2003 May-Jun

10.  Role of adipocyte differentiation-related protein in surfactant phospholipid synthesis by type II cells.

Authors:  C J Schultz; E Torres; C Londos; J S Torday
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

View more
  2 in total

1.  Evidence for decreased lipofibroblast expression in hypoplastic rat lungs with congenital diaphragmatic hernia.

Authors:  Florian Friedmacher; Naho Fujiwara; Alejandro Daniel Hofmann; Hiromizu Takahashi; Jan-Hendrik Gosemann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2014-07-15       Impact factor: 1.827

2.  Distinct Epithelial Cell Profiles in Normal Versus Induced-Congenital Diaphragmatic Hernia Fetal Lungs.

Authors:  Ana N Gonçalves; Jorge Correia-Pinto; Cristina Nogueira-Silva
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.